The AI newswire
CHICAGO, Ill. — June 2, 2025 — ImmuneOncia Therapeutics, Inc. (CEO Heung-Tae Kim) announced interim results today from the ongoing Phase 1b clinical trial of its next-generation CD47-targeting antibody, IMC-002,…
MILAN, Italy — May 30, 2025 — From May 24 to 27, 2025, the annual conference of the European Society of Human Genetics (ESHG) 2025 held successfully in Milan, Italy.…
Plasma proteomics analysis reveals hallmarks of treatment resistance, paving the way for personalized strategies in NSCLC immunotherapy BINYAMINA, Israel and CARY, N.C. — May 30, 2025 — OncoHost, a technology…
The WOPR Act (HB1806) sets national precedent for ethical limits on AI in therapy CHICAGO, Ill. — May 30, 2025 — Illinois is poised to become the first state to…
CHICAGO, Ill. — May 30, 2025 — Vaniam Group™, a leader in medical communications, is proud to announce the launch of Vaniam Intelligence™, our platform that integrates proprietary artificial intelligence…
PALO ALTO, Calif. — May 30, 2025 — Transcripta Bio today announced a research collaboration with Microsoft Research to accelerate the discovery of disease-gene associations using advanced artificial intelligence (AI)…
AIxMed and CorePlus team up to bring AI-driven quality control to improve bladder cancer diagnostics. SANTA CLARA, Calif. — May 30, 2025 — AIxMed, innovators and providers of an AI-powered…
NEW YORK, N.Y. — May 30, 2025 — Sigma Theta Tau International Honor Society of Nursing (Sigma) and Lecturio, the world’s most innovative digital healthcare education platform, today jointly announced…
Next-generation AI solution introduces new clinical features and broader disease detection for chest X-rays SEOUL, South Korea — May 28, 2025 — Lunit (KRX:328130.KQ), a leading provider of AI for…
SEOUL, South Korea — May 22, 2025 — Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology…